Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
The Journal of Clinical Endocrinology and Metabolism|September 8, 2022
Premature Ovarian Insufficiency in CLPB Deficiency: Transcriptomic, Proteomic and Phenotypic InsightsElena J Tucker, Megan J Baker, Daniella H Hock, et al.
Transfusion|May 29, 2013
High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference CenterMarjolaine Morgand, Marc Buffet, Marc Busson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 2, 2024
Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National CohortConstance Lahuna, Federica Defendi, Laurence Bouillet, et al.
Research and Practice in Thrombosis and Haemostasis|May 23, 2022
Immune-mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressureAdrien Joseph, Martin Eloit, Elie Azoulay, et al.
Kidney International Reports|July 9, 2025
Diagnostic Value of Biological Parameters in Biopsy-Confirmed Thrombotic Microangiopathy-MATRIX Consortium GroupJean-Michel Halimi, Anna Duval, Etienne Chardon, et al.
Eclinicalmedicine|April 16, 2025
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)Paul Coppo, Michael Bubenheim, Ygal Benhamou, et al.
Haematologica|January 8, 2026
Ethnicity affects relapse-free survival in immune-mediated thrombotic thrombocytopenic purpuraJúlia Weisinger, Florian Blanchard, Benoit Suzon, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2023
Differences in IgG autoantibody Fab glycosylation across autoimmune diseasesJana Koers, Rocco Sciarrillo, Ninotska I L Derksen, et al.
American Journal of Hematology|August 13, 2024
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodesJeremy W Jacobs, Caroline G Stanek, Garrett S Booth, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
The Journal of Clinical Endocrinology and Metabolism|September 8, 2022
Premature Ovarian Insufficiency in CLPB Deficiency: Transcriptomic, Proteomic and Phenotypic InsightsElena J Tucker, Megan J Baker, Daniella H Hock, et al.
Transfusion|May 29, 2013
High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference CenterMarjolaine Morgand, Marc Buffet, Marc Busson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 2, 2024
Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National CohortConstance Lahuna, Federica Defendi, Laurence Bouillet, et al.
Research and Practice in Thrombosis and Haemostasis|May 23, 2022
Immune-mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressureAdrien Joseph, Martin Eloit, Elie Azoulay, et al.
Kidney International Reports|July 9, 2025
Diagnostic Value of Biological Parameters in Biopsy-Confirmed Thrombotic Microangiopathy-MATRIX Consortium GroupJean-Michel Halimi, Anna Duval, Etienne Chardon, et al.
Eclinicalmedicine|April 16, 2025
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)Paul Coppo, Michael Bubenheim, Ygal Benhamou, et al.
Haematologica|January 8, 2026
Ethnicity affects relapse-free survival in immune-mediated thrombotic thrombocytopenic purpuraJúlia Weisinger, Florian Blanchard, Benoit Suzon, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2023
Differences in IgG autoantibody Fab glycosylation across autoimmune diseasesJana Koers, Rocco Sciarrillo, Ninotska I L Derksen, et al.
American Journal of Hematology|August 13, 2024
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodesJeremy W Jacobs, Caroline G Stanek, Garrett S Booth, et al.
Pageof 20